{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-04-01",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "San Diego",
      "state": "CA",
      "country": "United States",
      "classification": "Class II",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "62772",
      "recalling_firm": "Prometheus Laboratories Inc.",
      "address_1": "9410 Carroll Park Dr",
      "address_2": "N/A",
      "postal_code": "92121-5201",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Letter",
      "distribution_pattern": "Nationwide and Puerto Rico.",
      "recall_number": "D-1659-2012",
      "product_description": "Mercaptopurine Tablets, USP, 50 mg, packaged in a) 60-count tablets per bottle (NDC 49884-922-02) and b) 250-count tablets per bottle (NDC 49884-922-04), Rx only, Distributed by: Par Pharmaceutical Companies, Inc., Spring Valley, NY  10977.",
      "product_quantity": "a) 25,516 bottles; b) 2,569 bottles",
      "reason_for_recall": "Failed USP Dissolution Test Requirements: The recalled lots do not meet the specification for dissolution.",
      "recall_initiation_date": "20120629",
      "center_classification_date": "20120822",
      "termination_date": "20130327",
      "report_date": "20120829",
      "code_info": "Lot #s: a) 11A003, 11A004, 11A005, Exp 01/13; 11L071, 11L072, Exp 10/13; b) 11B009, Exp 01/13; 11L073, Exp 10/13"
    }
  ]
}